ACCESS Newswire
24 Nov 2022, 11:49 GMT+10
GOTHENBURG, SE / ACCESSWIRE / November 24, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 24, 2022 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson's disease, today announced that the company will present and participate at Redeye Life Science Day 2022 on Thursday, November 24, 2022.
Richard Godfrey, CEO, will participate in an interview segment at 11:40 CET on Thursday, November 24, 2022. A pre-recorded company presentation is available via the event platform. Follow the live broadcast at https://www.redeye.se/events/850947/redeye-life-science-day.
A recording of the interview and presentation will be made available on our company website, www.irlab.se, following the event.
For more information:
Richard Godfrey, CEO
Phone: +46 730 70 69 00
E-mail: [email protected]
About IRLAB
IRLAB discovers and develops novel treatments of Parkinson's disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam.
IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its proprietary systems biology-based Integrative Screening Process (ISP) research platform. In addition to IRLAB's strong clinical pipeline, the company is also progressing two preclinical programs, IRL942 and IRL757, towards Phase I studies. IRLAB is listed on Nasdaq Stockholm. More information on www.irlab.se.
Attachments
IRLAB to present at Redeye Life Science Day 2022
SOURCE: IRLAB Therapeutics
Get a daily dose of Illinois Intelligencer news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Illinois Intelligencer.
More InformationTORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
New Delhi [India], July 3 (ANI): A new trade agreement between the United States and Vietnam is raising concerns and offering key lessons...
Washington DC [US], July 3 (ANI): US State Department Deputy Spokesperson Mignon Houston on Wednesday (local time) stated that student...
Washington DC [US], July 3 (ANI): US State Department Deputy Spokesperson Mignon Houston on Wednesday (local time) said that India...
Multiple Kiev officials have criticized the halt of US weapon supplies Kiev is no longer a priority at the center of US foreign policy,...
Washington DC [US], July 3 (ANI): US State Department Deputy Spokesperson Mignon Houston on Wednesday (local time) said that India...
ISTANBUL/PARIS/BRUSSELS: As searing temperatures blanket much of Europe, wildfires are erupting and evacuation orders are being issued...
VENICE, Italy: Over the weekend, hundreds of protesters marched through the narrow streets of Venice to voice their opposition to billionaire...
PARIS, France: France is taking stronger steps to reduce smoking. A new health rule announced on Saturday will soon ban smoking in...
WASHINGTON, DC - U.S. President Donald Trump on Tuesday claimed Elon Musk's success has been built on government subsidies. Without...
EVERGLADES, Florida: Over the weekend, a diverse coalition of environmental activists, Native American leaders, and residents gathered...
BEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...